Dragana Prekajski is a Research Associate at Molecular Partners since September 2022, having previously served as a Research Associate Intern at Philochem AG from March to December 2021. Dragana earned a Master's degree in Integrated Studies, focusing on Pharmacy and Medical Biochemistry, from the University of Belgrade - Faculty of Pharmacy between 2010 and 2015. Furthering academic pursuits, Dragana completed a Master of Science in Pharmaceutical Sciences at ETH Zürich from September 2019 to December 2021.
This person is not in any offices
Molecular Partners
3 followers
About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.